OPTUS Pharmaceutical Co., Ltd. Stock Price

KOSDAQ:A131030 Community·₩188.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

A131030 Share Price Performance

₩0

-6630.00 (-100.00%)

₩0

-6630.00 (-100.00%)

₩0

Thu, 12 Mar 26

Share Pricen/a

A131030 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with acceptable track record.

3 Risks

2 Rewards

View Full Analysis

OPTUS Pharmaceutical Co., Ltd. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 633.76
: 55.80%
: 12.77%
: 0%

View Full Analysis

About A131030

Founded: 2002
Employees: n/a
CEO: Dong-Hwa Han
WebsiteView website: www.optuspharm.com

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea.